WU
32
2
LMT
34
2
EQIX
64
2
ROST
63
12
URI
65
5
AVY
53
3
A
43
2
VNO
60
10
PEP
48
6
JWN
48
6
BWA
48
2
HSIC
56
5
AXP
71
2
M
37
12
GOOGL
40
-5
ROK
62
15
CA
38
6
WDC
47
4
CTSH
56
2
EL
25
4
WU
32
2
LMT
34
2
EQIX
64
2
ROST
63
12
URI
65
5
AVY
53
3
A
43
2
VNO
60
10
PEP
48
6
JWN
48
6
BWA
48
2
HSIC
56
5
AXP
71
2
M
37
12
GOOGL
40
-5
ROK
62
15
CA
38
6
WDC
47
4
CTSH
56
2
EL
25
4
Financhill
Back

Ikena Oncology 10K Form

Sell
36

IKNA
Ikena Oncology

Last Price:
1.69
Seasonality Move:
7.58%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IKNA News And Ratings

See the #1 stock for the next 7 days that we like better than IKNA

IKNA Financial Statistics

Sales & Book Value

Annual Sales: $9.16M
Cash Flow: $-8.94M
Price / Cash Flow: 0
Annual Sales: $2.78
Price / Book: 0.61

Profitability

EPS (TTM): -1.22000
Net Income (TTM): $-59.6M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Ikena Oncology Earnings Forecast

Key Ikena Oncology Financial Ratios

  • The Research & Development expenses have been 651.22% of Revenue.
  • The Net Earning history of IKNA is -744.17% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Ikena Oncology Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: IKNA
Website: ikenaoncology.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IKNA Technical Analysis vs Fundamental Analysis

Sell
36
Ikena Oncology (IKNA) is a Sell

Is Ikena Oncology a Buy or a Sell?

  • Ikena Oncology stock is rated a Sell
    The current Ikena Oncology [IKNA] share price is $1.71. The Score for IKNA is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.